![](/img/cover-not-exists.png)
Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma
Yarlagadda, Bhavya, Kamatham, Vaishnavi, Ritter, Ashton, Shahjehan, Faisal, Kasi, Pashtoon M.Volume:
3
Journal:
npj Precision Oncology
DOI:
10.1038/s41698-019-0091-4
Date:
December, 2019
File:
PDF, 911 KB
2019